| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Against all odds
|
Nuechterlein, Brandon
|
|
|
10 |
9 |
p. e709
|
article
|
| 2 |
All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results
|
Kelkar, Amar H
|
|
|
10 |
9 |
p. e706-e707
|
article
|
| 3 |
All systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results – Authors' reply
|
Döhner, Hartmut
|
|
|
10 |
9 |
p. e707
|
article
|
| 4 |
Association between maternal haemoglobin concentrations and maternal and neonatal outcomes: the prospective, observational, multinational, INTERBIO-21st fetal study
|
Ohuma, Eric O
|
|
|
10 |
9 |
p. e756-e766
|
article
|
| 5 |
Correction to Lancet Haematol 2023; 10: e512–29
|
|
|
|
10 |
9 |
p. e708
|
article
|
| 6 |
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial
|
Lasocki, Sigismond
|
|
|
10 |
9 |
p. e747-e755
|
article
|
| 7 |
FIT for surgery: fractures, iron, and tranexamic acid
|
Ikeda, Kazuhiko
|
|
|
10 |
9 |
p. e699-e700
|
article
|
| 8 |
Haematological malignancies in pregnancy: time for accurate incidence data
|
Birsen, Rudy
|
|
|
10 |
9 |
p. e705
|
article
|
| 9 |
Haematological malignancies in pregnancy: time for accurate incidence data – Authors' reply
|
Mills, Georgia S
|
|
|
10 |
9 |
p. e705-e706
|
article
|
| 10 |
Maintaining MOMENTUM in myelofibrosis
|
Kremyanskaya, Marina
|
|
|
10 |
9 |
p. e697-e699
|
article
|
| 11 |
Measuring the global burden of anaemia
|
Pasricha, Sant-Rayn
|
|
|
10 |
9 |
p. e696-e697
|
article
|
| 12 |
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study
|
Gerds, Aaron T
|
|
|
10 |
9 |
p. e735-e746
|
article
|
| 13 |
Optimal haemoglobin concentration in pregnancy
|
Olaniyan, Halimat
|
|
|
10 |
9 |
p. e700-e702
|
article
|
| 14 |
Patients receiving allogeneic haematopoietic stem-cell transplantation and clinical outcomes after early access to palliative care
|
Späth, Christian
|
|
|
10 |
9 |
p. e777-e784
|
article
|
| 15 |
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
|
|
|
|
10 |
9 |
p. e713-e734
|
article
|
| 16 |
Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
|
Shallis, Rory M
|
|
|
10 |
9 |
p. e767-e776
|
article
|
| 17 |
Tackling the enormous global burden of anaemia
|
The Lancet Haematology,
|
|
|
10 |
9 |
p. e695
|
article
|
| 18 |
The challenge of defining the global burden of iron deficiency anaemia
|
Young, Melissa F
|
|
|
10 |
9 |
p. e702-e704
|
article
|
| 19 |
Understanding the barriers to AML care in India
|
Senapati, Jayastu
|
|
|
10 |
9 |
p. e710-e711
|
article
|
| 20 |
Virginia Abello Polo—a once-in-a-lifetime opportunity
|
Kirby, Tony
|
|
|
10 |
9 |
p. e712
|
article
|
Journal description